To further understand the opposing roles of CRABP1 and CRABP2 in breast cancer progression, we immunostained our breast cancer TMA with Ki67, a cell proliferation marker (Additional file 1: Figure S1), and examined its correlation with CRABP protein levels. Here, MKI67 is linked to breast carcinoma.